Booster Therapeutics

Booster Therapeutics is a startup founded in 2024. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Booster Therapeutics is developing a new class of small-molecule proteasome activator medicines designed to boost 20S proteasome activity and restore cellular protein homeostasis, initially focusing on neurodegenerative diseases. The company uses a structure-based DGRADX™ platform combining high-throughput screening, X-ray crystallography, and computational tools to build a pipeline of activator compounds.